A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)
Clinical trial NCT03565068 · COMPLETED
Trial details
- NCT number
- NCT03565068
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2020-04-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.